David Roman
Stock Analyst at Goldman Sachs
(2.29)
# 2,713
Out of 4,981 analysts
46
Total ratings
50%
Success rate
-0.99%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SI Shoulder Innovations | Initiates: Buy | $20 | $14.98 | +33.51% | 1 | Aug 25, 2025 | |
| CARL Carlsmed | Initiates: Buy | $19 | $14.73 | +28.99% | 1 | Aug 18, 2025 | |
| OMDA Omada Health | Initiates: Buy | $29 | $22.02 | +31.70% | 1 | Jul 1, 2025 | |
| HQY HealthEquity | Maintains: Neutral | $94 → $104 | $92.71 | +12.18% | 3 | Jun 4, 2025 | |
| BBNX Beta Bionics | Initiates: Neutral | $16 | $25.59 | -37.46% | 1 | May 30, 2025 | |
| PODD Insulet | Initiates: Buy | $380 | $342.11 | +11.08% | 1 | May 30, 2025 | |
| DOCS Doximity | Maintains: Neutral | $80 → $50 | $72.53 | -31.06% | 3 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $120 → $104 | $100.81 | +3.16% | 2 | May 6, 2025 | |
| TDOC Teladoc Health | Maintains: Buy | $13 → $10 | $7.67 | +30.46% | 4 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $94 → $82 | $77.98 | +5.16% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $24 → $23 | $22.81 | +0.86% | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $131.56 | +17.06% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $12.14 | +97.69% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $73.51 | -3.41% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $55.43 | -0.78% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $42 | $23.69 | +77.33% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $91 → $124 | $176.62 | -29.79% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $377.40 | +13.14% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $90 | $76.33 | +17.91% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $100.06 | -10.05% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $434.82 | +14.99% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $185.88 | +47.41% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $93.49 | -11.22% | 1 | May 30, 2024 |
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $14.98
Upside: +33.51%
Carlsmed
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $14.73
Upside: +28.99%
Omada Health
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $22.02
Upside: +31.70%
HealthEquity
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $92.71
Upside: +12.18%
Beta Bionics
May 30, 2025
Initiates: Neutral
Price Target: $16
Current: $25.59
Upside: -37.46%
Insulet
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $342.11
Upside: +11.08%
Doximity
May 21, 2025
Maintains: Neutral
Price Target: $80 → $50
Current: $72.53
Upside: -31.06%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $100.81
Upside: +3.16%
Teladoc Health
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.67
Upside: +30.46%
GE HealthCare Technologies
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $77.98
Upside: +5.16%
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $22.81
Upside: +0.86%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $131.56
Upside: +17.06%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $12.14
Upside: +97.69%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $73.51
Upside: -3.41%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $55.43
Upside: -0.78%
Feb 26, 2025
Reinstates: Buy
Price Target: $42
Current: $23.69
Upside: +77.33%
Feb 24, 2025
Maintains: Neutral
Price Target: $91 → $124
Current: $176.62
Upside: -29.79%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $377.40
Upside: +13.14%
Dec 5, 2024
Maintains: Buy
Price Target: $81 → $90
Current: $76.33
Upside: +17.91%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $100.06
Upside: -10.05%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $434.82
Upside: +14.99%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $185.88
Upside: +47.41%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $93.49
Upside: -11.22%